Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
CRVS
Corvus Pharmaceuticals, Inc.
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Corvus Pharmaceuticals, Inc. (CRVS) Earnings
Last reported
June 30, 2026
EPS Miss · -17.4%
EPS estimate
-$0.16
EPS actual
-$0.19
Revenue est.
—
Revenue actual
—
Related:
CRVS overview
·
CRVS financials
·
CRVS news